Cancer-specific viruses and the development of ONYX-015.
about
Adenoviral delivery of pan-caspase inhibitor p35 enhances bystander killing by P450 gene-directed enzyme prodrug therapy using cyclophosphamide+Mathematical modeling of tumor therapy with oncolytic viruses: regimes with complete tumor elimination within the framework of deterministic models.Adenoviral vectors for prodrug activation-based gene therapy for cancerOncolytic adenovirus research evolution: from cell-cycle checkpoints to immune checkpointsMathematical modeling of tumor therapy with oncolytic viruses: effects of parametric heterogeneity on cell dynamics.[Transcriptional inhibition of human papilloma virus in cervical carcinoma cells reactivates functions of the tumor suppressor p53].A new therapy for highly effective tumor eradication using HVJ-E combined with chemotherapy.Towards predictive computational models of oncolytic virus therapy: basis for experimental validation and model selection.Potential of vesicular stomatitis virus as an oncolytic therapy for recurrent and drug-resistant ovarian cancer.Indole-3-carbinol (I3C) increases apoptosis, represses growth of cancer cells, and enhances adenovirus-mediated oncolysisCdk5 phosphorylates non-genotoxically overexpressed p53 following inhibition of PP2A to induce cell cycle arrest/apoptosis and inhibits tumor progression.Heterochromatin silencing of p53 target genes by a small viral protein.Complex spatial dynamics of oncolytic viruses in vitro: mathematical and experimental approaches.Adenoviruses induce autophagy to promote virus replication and oncolysis.Virotherapy induces massive infiltration of neutrophils in a subset of tumors defined by a strong endogenous interferon response activity.Adenovirus ubiquitin-protein ligase stimulates viral late mRNA nuclear export.Gene therapy of benign gynecological diseases.Immunocompetent syngeneic cotton rat tumor models for the assessment of replication-competent oncolytic adenovirusComplex Dynamics of Virus Spread from Low Infection Multiplicities: Implications for the Spread of Oncolytic Viruses.Enhancement of intratumoral cyclophosphamide pharmacokinetics and antitumor activity in a P450 2B11-based cancer gene therapy model.Feasibility of herpes simplex virus type 1 mutants labeled with radionuclides for tumor treatment.Adenovirus with DNA Packaging Gene Mutations Increased Virus Release.Oncolytic viruses: do they have a role in anti-cancer therapy?Progress in oncolytic virotherapy for the treatment of thyroid malignant neoplasm.p53-induced apoptosis occurs in the absence of p14(ARF) in malignant pleural mesothelioma.Computational modeling approaches to the dynamics of oncolytic viruses.ODE models for oncolytic virus dynamics.Development of an Oncolytic Adenovirus with Enhanced Spread Ability through Repeated UV Irradiation and Cancer SelectionUse of oncolytic viruses for the eradication of drug-resistant cancer cells.
P2860
Q21261309-B1B8B39D-0423-4BF7-866A-5C570226F280Q25257260-22D10302-2AF8-4B28-AA4E-6190D5CEE1E8Q26860729-5B542F6D-6A24-4CDF-A38C-9CB826D9A84DQ28083515-F1E2ECDD-8AEA-499A-A7D5-72BD015F9FCAQ33259239-F7BD8834-01B6-4427-BEA3-49EC65C14120Q33293557-8C71014A-A28A-4F6C-8005-FDE8CC227480Q33299767-A8B0D070-C00A-4FC1-9EF2-F562293BCEAFQ33404103-075B6AA7-0AD0-468B-AF85-7E116AA8C384Q33579385-3C9D08F9-6A0E-4FC7-B749-47A9FFF0454AQ34028482-A2012BEA-B824-4535-8520-A6A52417D5AEQ34068211-7DFCBB1C-135A-4B0F-8ACC-10B4C93428BCQ34091002-29DADAD3-809D-4290-8B9F-9846EB3D2AF1Q34311524-9A3097AE-FC04-416C-93F1-735318183790Q35040642-29682D0C-7EEE-40B3-BC68-188AEB5E8B3BQ35387710-716ADD69-30A1-4E93-A914-9978C7D0858DQ35634994-08F89894-FB85-41A7-A284-0E68BC7BEF35Q35770271-0DBC31AE-2FB4-4C92-87CB-5B68148EE470Q36184357-6CE25F71-690F-4AD6-8682-04762FAA7E9AQ36255281-2871BF5A-7DDB-4150-96AD-E85B564CE1FFQ37037051-C6A5AAD4-3AD5-47E0-91ED-DEE6132B436BQ37103315-CC7CA200-01DA-4274-9DA6-CBBB222AA927Q37539305-331E22A8-7D02-44B1-BF42-C99D2D9F59BCQ37926486-13C9A2F1-8547-400E-982D-C27830BE3943Q38264652-4539F59C-8595-4B78-B1E1-B067E51FF628Q38311193-B5796DD4-50AF-4DB5-980E-84C4C5549A4EQ38784057-BF67DF90-BA69-474C-AAC0-EE81797D2475Q39634544-93E51B8C-E9B4-49BF-BCC6-16B7C0601F61Q40695592-1475A1D2-DB6C-4015-B29D-F404A5CA96E4Q43159083-69D5B675-F4C3-4F61-87BE-1384B789986A
P2860
Cancer-specific viruses and the development of ONYX-015.
description
2003 nî lūn-bûn
@nan
2003 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
Cancer-specific viruses and the development of ONYX-015.
@ast
Cancer-specific viruses and the development of ONYX-015.
@en
type
label
Cancer-specific viruses and the development of ONYX-015.
@ast
Cancer-specific viruses and the development of ONYX-015.
@en
prefLabel
Cancer-specific viruses and the development of ONYX-015.
@ast
Cancer-specific viruses and the development of ONYX-015.
@en
P1476
Cancer-specific viruses and the development of ONYX-015
@en
P2093
Frank McCormick
P304
P433
P577
2003-07-01T00:00:00Z